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Exercise-induced asthma is a common phenomenon, the mechanism of which is undetermined. Eosinophils have
been suggested as playing a role in its occurrence. We studied the effect of exercise-induced asthma on the cellular
and mediator composition of spontaneously obtained sputum.
Twenty-five patients with bronchial asthma were investigated by studying sputum spontaneously obtained before
and following challenge. One group with (n¼9) and one without (n¼9) exercise-induced asthma performed exercise
challenge. A third group (n¼7) performed methacholine challenge. The sputum was analysed using Giemsa staining
for differential cell count, measuring eosinophil cationic proteins and mixtures of leukotrienes (D4, E4 and C4) in
the liquid phase using ELISA.
The group with exercise-induced asthma had a mean drop of 23?7+7?4% in FEV1, significantly (P¼0?001)
higher than the group without it. Following challenges, there were significant increases in sputum eosinophils only
in the group with exercise-induced asthma (from 8?1+13?9% to 18?3+20?2%, P¼0?0017) and not in control
groups (from 0?9+0?9% to 1?5+1?5% ) or in those who had methacholine challenge (from 23?6+27?2% to
22?3+23?8%). Eosinophil cationic proteins did not change significantly in any group. In the liquid phase of the
sputum, the amount of leukotrienes increased following exercise in six of the seven patients with exercise-induced
asthma in whom it was measured.
The influx of eosinophils to the airway in patients who develop exercise-induced asthma can be partially
explained by the leukotrienes in the airways of those patients.
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Patients with bronchial asthma often develop exercise-
induced asthma (EIA) when they perform exercise of
sucient duration and intensity (1). It is well accepted that
heat loss, dependent on temperature and humidity of the
inspired air, is directly related to the post-exercise
bronchoconstriction phenomenon (2,3). It was suggested
that the rate of airway rewarming, rather than cooling,
determines the intensity of the asthma following exercise
(4).
The relationship between mediators release and EIA is
controversial. Broide et al. carried out fibre-optic broncho-
scopy after exercise and could find no evidence of mast cell
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technique and did find a correlation between the severity of
EIA and the sputum eosinophil percentage and the level of
eosinophil cationic proteins (ECP) (6).
The role of eosinophils in exercise-induced asthma has
not been adequately studied. We evaluated the effect of
exercise on eosinophil influx to the airways in patients with
and without EIA by means of a spontaneously obtained
sputum technique. We also concomitantly measured ECP
and leukotrienes, mediators involved in the activation and
migration of the eosinophils, in the same sputum.
Methods
PATIENTS AND STUDY DESIGN
Forty-nine asthmatic patients were recruited from the
outpatient clinic at the Tel Aviv Sourasky Medical Center
and were enrolled in the study [Table 1(a–c)]. They all met
the American Thoracic Society Criteria for Bronchial# 2000 HARCOURT PUBLISHERS LTD
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spontaneously and they comprised the study population.
The participants were divided into three groups: group 1
(n¼9) were patients who were previously shown to have an
EIA of 15% drop in FEV1 following exercise [Table 1(a)];
group 2 (n¼9) were patients without EIA [Table 1(b)];
group 3 (n¼7) were patients who had a clinical history of
asthma and who underwent methacholine inhalation
challenge [Table 1(c)]. The three groups were matched for
age and baseline FEV1 % or FEV1/FVC%.
All the patients were relatively mild asthmatics and were
treated only with inhaled salbutamol as needed. They all
had stable disease during the previous 6 weeks. All the
patients were atopic, being skin-sensitive (prick test) to
either mites, pollens, molds, epidermals or a combinations
thereof.
All the patients signed a consent form fulfilling the
requirements of the local ethics committee.
EXERCISE CHALLENGE
Patients from groups 1 and 2 underwent the exercise
challenge procedures as recommended (8). Challenge was
performed for 8min on a treadmill (Quinton, U.S.A.)
during which the heart rate reached 85% of maximal
predicted value. Spirometry was carried out prior to
exercise and 5 and 10min following the challenge. The
change in forced expiratory volume in 1 sec of expiration
(FEV1) was calculated. During the entire study, the room
temperature was 22–248C and the relative humidity was
maintained between 60 and 70%.
METHACHOLINE CHALLENGE
The methacholine challenge procedure was a modification
of Chai et al.’s method (9). Five breaths of increasing
concentrations of methacholine (Spectrum Quality Pro-
ducts Inc., Gardena, CA, U.S.A.) (0?07, 0?15, 0?3, 0?6, 1?5,
3?0, 6?0, 12mg%) were inhaled from functional residual
capacity to total lung capacity. Spirometry was carried out
at baseline and 3–5min following each concentration. The
challenge was stopped when a 20% or more drop in FEV1
occurred.
SPIROMETRY
A Fukuda Spiro analyser ST 300 (Sangio Co. Ltd, Japan)
was used for recording spirometry. The best of three
consecutive measurements was selected.
SPUTUM EXAMINATION
To avoid induction of sputum by inhaled hypertonic saline,
we included only those patients who were able to provide
sputum spontaneously. The sputum was collected at
approximately the same time of day, both at baseline as
well as during bronchoconstriction.The sputum was examined within 2 h of collection and
plugs were selected. Dithiothreitol (DTT, Sputalysin,
Calbiochem, San Diego, CA, U.S.A.), freshly prepared in
a dilution of 1:10 with distilled water, was added in a
volume (in ml) equal to double the weight. The mechanically
mixed cell suspension was incubated for 20min in a 378C
water bath. The DTT effect was stopped by adding equal
volumes of phosphate-buffered saline. The suspension was
centrifuged and the supernatant was stored in six Eppen-
dorf tubes at 7808C and filtered through 52mm nylon
gauze (BNSH Thompson, Scarborough, Ontario, Canada)
to remove debris and mucus. The total cell content was
cytocentrifuged (Shandon Southern Instruments, Sewick-
ley, PA, U.S.A.) at 1000 rpm for 5min and stained by
Giemsa. Two hundred cells were counted. Eosinophil
cationic protein (ECP) and leukotrienes (a mixture of E,
C, D4) were measured from the liquid phase as described
elsewhere (10).
EXPERIMENTAL PROTOCOL
All studies were done between 08?00 and 10?00 hours. Each
study patient performed exercise challenge. Methacholine
inhalation challenge was also performed for comparison.
This allowed us to delineate the specific mechanism of
exercise-induced asthma, separating it from other physio-
logical triggers for bronchoconstriction. Spirometry was
performed at baseline and following the provision of
sputum. In none of the patients was there subsequent
changes greater than 5% in FEV1.
Each patient participated in a designated challenge.
Sputum was collected before challenge and again when a
significant drop in FEV1 occurred (group 1) or 5–10min
following exercise (group 2). Sputum was also collected
before methacholine challenge and was repeated when a
significant drop in FEV1 occurred.
MATERIALS
ECP was measured using an RIA commercial kit (Amer-
sham-Pharmacia, UK Biotech). Leukotrienes assay was
carried out using a commercially available kit (Bulman
Lab, AG, Allschwill, Switzerland) as described elsewhere
(11). Briefly, mononuclear cells were isolated by sedimenta-
tion with dextran and stimulated with an increasing dose of
aspirin together with interleukin-3. The supernatants were
collected and stored at 7208C. The sulpholeukotrienes
which were released were measured using an ELISA kit. A
single monoclonal antibody was used for detecting leuko-
trienes and their metabolites, D4 and E4.
STATISTICAL ANALYSIS
Mean and standard deviations (SD) were calculated. The
three groups were compared by analysis of vatiance
(ANOVA), using a Kruskal-Wallis test. Significance was
set at P50?05.
TABLE 1. Characteristics of patients who (a) underwent exercise challenge with exercise-induced asthma, (b) underwent
exercise challenge without EIA and (c) underwent methacholine inhalation challenge
(a)
No. Age (years) Duration (years) Sex B. FEV1 % B. FEV/VC % DFEV1% to exercise
1 19?5 410 M 88 81 17
2 15 8 M 90 82 28
3 17 410 F 79 78 26
4 18 410 F 90 81 20
5 23 410 M 75 71 20
6 19 410 F 91 88 16
7 21 7 M 89 81 23
8 19 410 M 77 80 21
9 21 410 F 86 65 42
Mean+SD 19?1+2?4 85+5?9 79?1+6?3 23?7+7?4
(b)
No. Age (years) Duration (years) Sex B. FEV1% B. FEV/FVC % DFEV1% to exercise
1 18?5 3 M 90 90 3
2 19 7 F 80 87 6
3 18?5 410 M 83 85 12
4 17 410 M 88 98 0
5 20 410 F 81 77 10
6 19 3 F 83 72 8
7 20 2 M 85 76 0
8 19 410 F 86 90 0
9 22 5 F 82 78 5
Mean+SD 19?22 84?2+3?3 83?61+8?4 4?8+4?2
(c)
No. Age (years) Duration of
illness (years)
Sex B. FEV1% B. FEV1/
FVC%
1 19 9 M 75 77
2 22 5 M 78 74
3 18 410 F 81 76
4 16 410 M 80 73
5 19 8 F 77 79
6 23 9 F 73 80
7 25 6 M 84 75
Mean+SD 20?3+2?9 78?3+3?4 76+2?4
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As shown in Table 1(a–c), the three groups described were
matched in terms of mean age, baseline FEV1% and FEV1/
FVC%. Although disease duration was longer in groups 1a
and 1c than 1b, it did not seem to effect baseline FEV1.
Groups a and b differed significantly (P50?001) in terms of
their response to exercise, with a mean drop in FEV1 of
23?7+7?4% in group a and 4?8+4?2% in group b.When the sputum cell count was analysed at baseline
(Tables 2–4), a significantly higher percent of eosinophils
was found in groups a and c compared to b. In patients 2
and 9 from group a, the greatest drop in FEV1 following
exercise was seen with the highest percentage of baseline
sputum eosinophils. Bronchial provocation with exercise or
methacholine significantly increased sputum eosinophils
only in group a (from 8?1+13?9 to 18?3+20?2, P¼0?0017,
Table 2), in which exercise induced a drop in FEV1.
TABLE 2. Cells recovered from sputum of patients with exercise-induced asthma
Metach. (%) EOS (%) MaCR (%) Lymphocytes (%) Neutrophils (%)
No. BE PE BE PE BE PE BE PE BE PE
1 0?8 0?0 0?4 4?6 13?2 19?4 24?4 12?4 61?2 63?6
2 2?6 3?2 16?6 22?6 24?4 25?8 23?2 21?2 33?2 27?2
3 1?0 2?2 0?8 19?0 19?4 19?2 21?4 15?6 57?4 44?0
4 1?2 3?2 2?4 8?4 38?0 34?4 10?8 16?4 47?6 38?6
5 0?0 8?0 3?6 12?0 12?0 27?2 0?6 4?8 83?8 48?0
6 0?6 1?2 1?6 9?8 84?6 83?2 6?4 7?2 6?8 2?8
7 0?4 3?2 2?0 7?2 28?0 30?6 49?2 42?8 20?4 16?2
8 1?1 0?9 3?0 11?8 42?0 40?0 38?2 35?0 15?2 12?5
9 1 0?5 43?0 70?0 5 23 5 6 43?0 0?5
Mean+SD 0?9
+0?1
2?4
+8?2
8?1
+13?3
18?3
+20?2
29?6
+22?5
33?6
+19?7
19?9
+15?2
17?9
+12?2
40?9
+23?3
28?1
+21?8
Abbreviations: Metach.: metachromatic cells; EOS: eosinophils; MaCR: macrophages; BE: before exercise; PE: post-
exercise.
TABLE 3. Cells recovered from sputum of patients without exercise-induced asthma
Metach. (%) EOS (%) MaCR (%) Lymphocytes (%) Neutrophils (%)
No. BE PE BE PE BE PE BE PE BE PE
1 2?4 0?8 2?8 4?8 14?4 63?0 17?4 8?6 63?0 22?8
2 0?0 0?0 1?0 1?4 12?0 11?6 9?0 13?0 78?0 74?0
3 2?4 2?0 1?0 1?0 5?8 9?0 5?8 9?0 85?0 80?0
4 0?0 0?4 0?6 1?6 82?8 88?2 13?2 10?0 2?4 0?8
5 2?0 3?2 0?4 0?4 8?2 30?8 9?4 8?8 80?0 56?8
6 0?6 2?4 0?4 0?2 26?8 5?2 14?2 16?6 58?0 76?2
7 0?0 0?0 0?0 0?4 6?2 8?0 2?2 3?6 91?2 88?0
8 0?0 0?0 0?0 0?0 35?0 17?0 15?0 15?0 46?0 65?0
9 1?5 2?0 2?0 3?2 15?2 39?3 18?2 7?4 60?4 26?0
Mean 1?0 1?2 0?9 1?5 22?9 32?5 11?6 10?2 62?7 54?4
+SD 1?1 1?2 0?9 1?5 24?5 30?3 5?4 3?9 26?9 30?5
Abbreviations: see Table 2.
TABLE 4. Cells recovered from sputum of patients with methacholine-induced bronchoconstriction
No. PC20 Metach. (%) EOS (%) MaCR (%) Lymphocytes (%) Neutrophils (%)
mg%
methacholine
BM PM BM PM BM PM BM PM BM PM
1 12 0 3 4 39 17 7 2 49 77
2 10 2 1 6 7 28 30 10 18 72 36
3 0?1 0 0 59 60 22 29 6 9 3 5
4 0?07 2 3 35 40 38 35 5 4 19 16
5 8 0 0 0?5 1 56 43 8 10 35 33
6 0?6 0 0 2 3 19 25 5 8 71 62
7 6 0 0 60 39 21 30 16 9 3 0
Mean+SD 5?25
+4?64
0?7
+0?8
0?6
+1?0
23?6
+27?2
22?3
+23?8
31?8
+12?3
29?9
+7?5
8?1
+3?6
8?6
+4?7
36?0
+87?1
32?7
+26?5
Abbreviations: PC20: provocation concentration inducing 20% drop in FEV1. BM: before methacholine; PM: post
methacholine. For other abbrevations, see Table 2.
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TABLE 7. Mediators in sputum before and after methacho-
line-induced bronchoconstriction
No. ECP (mgml71) Leukotrienes (pgml71)
BM PM BM PM
1 60 70 1655 1692
2 10 15 113 200
3 35 23 159 45
4 40 50 606 45
5 5 5 ND ND
6 8 5 1059 289
7 100 85 534 104
Mean 37 36 687 395
+SD +22 +26 +585 +642
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following exercise in group a (from 40?9+23?3% to
28?1+21?8%, P50?05); there were no significant changes
in the other cell types (Tables 3 and 4). As shown in Tables
5–7 there was no significant difference in the baseline ECP
of the three groups, nor was there any significant effect of
the three challenges on these values.
Shown in Tables 5–7, sputum leukotriene values were not
significantly different at baseline among the three groups. In
six of the seven patients in group a, in whom leukotrienes
were examined, exercise significantly increased the levels of
this mediator. No correlation was seen between the degree
of changes in the leukotrienes value and the percentage
drop in FEV1. No similar effect was seen following exercise
in the non-EIA group or in those participants who
underwent methacholine inhalation challenge.TABLE 5. Mediators in sputum, before and following
challenge in group 1a with exercise-induced asthma
No. ECP (mgml71) Leukotrienes (pgml71)
BE PE BE PE
1 80 190 ND ND
2 90 70 559 1125
3 300 200 125 110
4 30 30 97 292
5 8 90 116 2961
6 10 25 ND ND
7 90 70 25 560
8 150 130 660 780
9 95 210 610 990
Mean 95 112 313 974*
+SD 95 75 280 947
BE: before exercise; PE: post-exercise; ND: not done.
*P¼0?06.
TABLE 6. Mediators in sputum, before and following
challenge in patients without exercise-induced asthma
No. ECP (mgml71) Leukotrienes (pgml71)
BE PE BE PE
1 2 8 ND ND
2 12 13 280 230
3 55 70 ND ND
4 200 32 1110 800
5 200 25 760 450
6 27 210 1160 810
7 8 10 540 650
8 8 90 400 90
9 300 15 4240 1708
Mean 90 52 1212 676
+SD 112 65 1375 531
For abbreviations, see Table 5.
For abbreviations, see Table 4.Discussion
Despite the wide prevalence and clinical significance of
EIA, the mechanism by which it manifests its effects is not
yet clear. One, among the many, proposed theories is that
EIA can be caused by inflammatory mediators (12).
Hyperventilation associated with exercise leads to heat
and water loss and hyperosmolarity of the airway’s mucosal
surface, resulting in mast cell degranulation. This theory
has been widely acclaimed but not adequately substan-
tiated. Indeed, anti-histamine (13) and leukotriene receptor
antagonists (14) were shown to diminish EIA.
Few studies have addressed the possible role of
eosinophils in exercise-induced asthma. Venge et al.
reported that the severity of EIA correlates with ECP
levels in the serum of asthmatic patients (15).
In the study by Tatieshi and his group (16), no change in
sputum eosinophils were found after exercise challenge.
However the authors collected the sputum at 0–2 h after the
exercise, and again 6–9 h later. We think that spreading the
collections over 2 h might have an effect on their results.
More recently, Yoshokawa et al., using an induced sputum
technique, provided evidence that the severity of broncho-
constriction evoked by exercise is closely related to
eosinophilic airway inflammation (6).
We also applied an induced sputum technique for
studying the influx of cells and the release of mediators in
the airways of patients who developed post-exercise
bronchoconstriction. For comparison, we also studied
asthmatic patients without EIA and those who underwent
methacholine inhalation challenge.
The sputum was collected in a spontaneous manner at
baseline and at the time of bronchoconstriction. We were
able to confirm Yoshokawa and colleague’s findings that
the severity of EIA correlates with the baseline degree of
airway eosinophils and, even more interesting, that there
was a significant increase in eosinophil numbers during
bronchoconstriction only in the group with EIA and not in
those without it or in those who underwent methacholine
challenge.
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composition of sputum in the airways in a recent study (17).
This, together with our findings, argues against the
possibility of increased recruitment of eosinophils already
present before exercise. In our patients with EIA, the
increase in airway eosinophils did not parallel increased
ECP, a marker of eosinophil activation. An increase in
eosinophils in the bronchoalveolar lavage was previously
shown to occur (18), but this was tested 3 h after the
completion of the exercise when the symptoms had already
resolved.
In six of the seven patients with EIA who were tested for
airway leukotriene levels, they were seen to have increased
in the airways. This only occurred in those patients who
had EIA and not in those without EIA or in the subjects
following methacholine challenge. It is therefore possible
that eosinophils release leukotrienes, leading to broncho-
constriction, or that leukotrienes released from another
source caused eosinophil migration to the airways. This
finding of an increase in leukotrienes release also explains
the inhibition of EIA by leukotriene receptor antagonists
(14).
Our findings clearly support the contention that eosino-
phils and leukotrienes play a role in EIA.
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